Degradation pathways: A case study with pegylated l-asparaginase

被引：0
|
作者：
Patel, Chintan [1 ]
Bandyopadhyay, Sanjay [1 ]
Patel, Gayatri C. [2 ]
机构：
[1] Department of Biotechnology, Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad,Gujarat, India
[2] Department of Pharmaceutics & Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa Campus, Changa, Anand,Gujarat,388 421, India
来源：
Pharmaceutical Technology | 2019年 / 43卷 / 04期
关键词：
Manufacture - Freezing - Storage (materials) - Drug products - Thawing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：40 / 48
相关论文
共 50 条
  • [31] PEGylated recombinant L-asparaginase from Erwinia carotovora: Production, properties, and potential applications
    N. S. Melik-Nubarov
    I. D. Grozdova
    G. Yu. Lomakina
    M. V. Pokrovskaya
    V. S. Pokrovski
    S. S. Aleksandrova
    O. Yu. Abakumova
    O. V. Podobed
    D. V. Grishin
    N. N. Sokolov
    Applied Biochemistry and Microbiology, 2017, 53 : 165 - 172
  • [32] PEGylated Recombinant L-Asparaginase from Erwinia carotovora: Production, Properties, and Potential Applications
    Melik-Nubarov, N. S.
    Grozdova, I. D.
    Lomakina, G. Yu.
    Pokrovskaya, M. V.
    Pokrovski, V. S.
    Aleksandrova, S. S.
    Abakumova, O. Yu.
    Podobed, O. V.
    Grishin, D. V.
    Sokolov, N. N.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2017, 53 (02) : 165 - 172
  • [33] Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase
    Tapasvi Modi
    David Gervais
    Investigational New Drugs, 2022, 40 : 21 - 29
  • [34] Immunogenicity Profile in Mice of a Pegylated Recombinant Erwinia Chrysanthemi-Derived L-Asparaginase
    Allas, Soraya
    Sahakian, Pierre
    Fichtner, Iduna
    Abribat, Thierry
    BLOOD, 2009, 114 (22) : 803 - 803
  • [35] Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase
    Modi, Tapasvi
    Gervais, David
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 21 - 29
  • [36] Pharmacokinetics and Pharmacodynamics in Mice of a Pegylated Recombinant Erwinia Chrysanthemi-Derived L-Asparaginase
    Allas, Soraya
    Sahakian, Pierre
    Fichtner, Iduna
    Abribat, Thierry
    BLOOD, 2009, 114 (22) : 803 - 803
  • [37] THE NEUROTOXICITY OF L-ASPARAGINASE REVISITED
    WHITE, L
    FISHMAN, LS
    SHORE, NA
    LANDING, BH
    JOURNAL OF PEDIATRICS, 1982, 101 (03): : 484 - 485
  • [38] EXTRACORPOREAL IMMUNOSUPPRESSION WITH L-ASPARAGINASE
    SAMPSON, D
    EUROPEAN SURGICAL RESEARCH, 1973, 5 : 17 - 17
  • [39] L-ASPARAGINASE INDUCED COAGULOPATHY
    GRALNICK, HR
    HENRY, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1969, 10 (MAR): : 32 - &
  • [40] L-ASPARAGINASE AND LYMPHOCYTE BLASTOGENESIS
    FIDLER, IJ
    MONTGOMERY, PC
    FERGUSON, E
    LANCET, 1971, 2 (7733): : 1091 - +
12345